Clara is a personalized, highly sensitive digital screening tool we have developed to identify early stage mild cognitive impairment and preclinical Alzheimer’s disease.
Dementia is the fastest growing major cause of disability globally, and early detection is crucial in changing its trajectory – With the current delayed diagnosis, the impact of the existing caring tools is low, and the ability to develop new therapies is limited. The existing cognitive screening methods available today for Alzheimer's disease do not identify individuals early enough, and they are expensive, inaccurate, time consuming and anxiety provoking. How can we challenge the current approach for understanding Alzheimer?
We now realize that the big tragedy of Alzheimer is not limited to simple memory loss, but is about losing your personhood and your ability to mentally map the people, events and places that form your life and identity. Clara is a highly engaging, predictive and data driven chat app, that uses self-referenced estimations of people, events and places to easily and precisely identify early stage mild cognitive impairment, through remote screening and ongoing monitoring. The scientific foundation is based on the activation of the orientation neural network, identified in our published research as overlapping the regions affected in Alzheimer's disease. We have developed Clara versions for web, Android, and an admin back office, which enables physicians, as well as nurses, social workers and neuropsychologists, to run the assessment and continuously track and monitor its results.
